BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16910096)

  • 1. The relationship between tumors and the lymphatics: what more is there to know?
    Sleeman JP
    Lymphology; 2006 Jun; 39(2):62-8. PubMed ID: 16910096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From tumor lymphangiogenesis to lymphvascular niche.
    Hirakawa S
    Cancer Sci; 2009 Jun; 100(6):983-9. PubMed ID: 19385973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lymphangiogenesis in cancer.
    Sundar SS; Ganesan TS
    J Clin Oncol; 2007 Sep; 25(27):4298-307. PubMed ID: 17878481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics.
    Ji RC
    Cancer Metastasis Rev; 2006 Dec; 25(4):677-94. PubMed ID: 17160713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphangiogenesis and tumor metastasis.
    Pepper MS; Tille JC; Nisato R; Skobe M
    Cell Tissue Res; 2003 Oct; 314(1):167-77. PubMed ID: 12883995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenesis, inflammation and metastasis.
    Schoppmann SF
    Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic vessel activation in cancer.
    Das S; Skobe M
    Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular markers for the study of tumour lymphangiogenesis.
    Jackson DG
    Anticancer Res; 2001; 21(6B):4279-83. PubMed ID: 11908682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review).
    Schoppmann SF; Horvat R; Birner P
    Oncol Rep; 2002; 9(3):455-60. PubMed ID: 11956609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-lymphatic interactions in an activated stromal microenvironment.
    Wong SY; Hynes RO
    J Cell Biochem; 2007 Jul; 101(4):840-50. PubMed ID: 17177186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and cancer metastasis.
    Stacker SA; Achen MG; Jussila L; Baldwin ME; Alitalo K
    Nat Rev Cancer; 2002 Aug; 2(8):573-83. PubMed ID: 12154350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking neuropilin-2 function inhibits tumor cell metastasis.
    Caunt M; Mak J; Liang WC; Stawicki S; Pan Q; Tong RK; Kowalski J; Ho C; Reslan HB; Ross J; Berry L; Kasman I; Zlot C; Cheng Z; Le Couter J; Filvaroff EH; Plowman G; Peale F; French D; Carano R; Koch AW; Wu Y; Watts RJ; Tessier-Lavigne M; Bagri A
    Cancer Cell; 2008 Apr; 13(4):331-42. PubMed ID: 18394556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor lymphangiogenesis in metastatic spread.
    Stacker SA; Baldwin ME; Achen MG
    FASEB J; 2002 Jul; 16(9):922-34. PubMed ID: 12087053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why and how do tumors stimulate lymphangiogenesis?
    Cao Y
    Lymphat Res Biol; 2008; 6(3-4):145-8. PubMed ID: 19093786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.